Vir Biotechnology Inc (VIR) Stock Price, Quote, News & History

VIRNASDAQ
$10.67
-0.16-1.48%
At close: Apr 21, 5:00 PM EST
$10.80
-0.03-0.28%
Pre-Market: 4:10 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-391.78M
Investing Cash Flow (TTM)
310.37M
Financing Cash Flow (TTM)
3.79M
Free Cash Flow (TTM)
-396.61M
Capital Expenditure (TTM)
-4.83M
Net Change in Cash (TTM)
-77.63M

Analyst Trends and Forecast

1
Dec 25
5
Feb
1
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.35B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
22.26
PB Ratio (TTM)
2.25
Earnings Yield % (TTM)
-29.56%
Earnings Yield % (FWD)
-7.58%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$4.75

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$232.19M
Debt to Equity
0.13
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$10.67
Volume / Avg.
14.05K / 3.52M
Day Range
- - -
52 Wk Range
4.16 - 11.66
Market Cap
$1.74B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
64
Short Interest
10.58%
Days to Cover
7.69

About

Sector
Health Care
Industry
Biotechnology
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Vir Biotechnology (VIR) stock?

A

You can purchase shares of Vir Biotechnology (NASDAQ:VIR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Vir Biotechnology (VIR) competitors?

Q

What is the forecast, or price target, for Vir Biotechnology (VIR) stock?

A

Vir Biotechnology has a consensus price target of $27.67.

Q

What is the current price for Vir Biotechnology (VIR)?

A

The stock price for Vir Biotechnology (NASDAQ: VIR) is $10.8 last updated April 23, 2026 at 4:00 AM EDT.

Q

Does Vir Biotechnology (VIR) pay a dividend?

A

There are no upcoming dividends for Vir Biotechnology.

Q

When is Vir Biotechnology (NASDAQ:VIR) reporting earnings?

A

Vir Biotechnology does not have any upcoming earnings scheduled.

Q

Is Vir Biotechnology (VIR) going to split?

A

There is no upcoming split for Vir Biotechnology.

Q

What sector and industry does Vir Biotechnology (VIR) operate in?

A

Vir Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.